402 results on '"Fox, Ira J."'
Search Results
2. Variants in autophagy genes MTMR12 and FAM134A are putative modifiers of the hepatic phenotype in α1-antitrypsin deficiency
3. Biofabrication of synthetic human liver tissue with advanced programmable functions
4. Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism
5. Prevention of Acute Liver Failure in Rats with Reversibly Immortalized Human Hepatocytes
6. Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency
7. Clinical Hepatocyte Transplantation: What Is Next?
8. Hepatocyte Transplantation
9. A non-human primate model of acute liver failure suitable for testing liver support systems
10. A Nonhuman Primate Model of Human Radiation-Induced Venocclusive Liver Disease and Hepatocyte Injury
11. Use of differentiated pluripotent stem cells as replacement therapy for treating disease
12. New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants
13. Resetting the transcription factor network reverses terminal chronic hepatic failure
14. Resolution of hepatic fibrosis after ZFN-mediated gene editing in the PiZ mouse model of human α1-antitrypsin deficiency.
15. Liver and Hepatocyte Xenotransplantation∗∗Work in the authors’ laboratories is supported by grants from the National Institutes of Health.
16. Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver‐Enriched Transcription Factors and Functional Proteins in End‐Stage Cirrhotic Human Hepatocytes
17. Induced pluripotent stem cells model personalized variations in liver disease resulting from α1-antitrypsin deficiency
18. Effects of edaravone, a radical scavenger, on hepatocyte transplantation
19. Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytes
20. STEM CELL THERAPY: Use of differentiated pluripotent stem cells as replacement therapy for treating disease
21. Parent perspectives on decisions to participate in a phase I hepatocyte transplant trial
22. Review of hepatocyte transplantation
23. Synthetic human livers for modeling metabolic diseases
24. Engineering liver tissue from induced pluripotent stem cells: A first step in generating new organs for transplantation?
25. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder
26. Hepatocyte Transplantation
27. Tolerable limits to whole liver irradiation in non-human primates: 1674
28. Rescue of hepatic function in rats with advanced cirrhosis and end-stage liver failure following delivery of HNF4a: 1284
29. Changes in Glycolysis are an Important Mechanism for Maintaining Cell Survival in Hepatic Failure in Advanced Cirrhosis: 1249
30. Human Hepatocyte Transplantation
31. The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis
32. Immunochemical Properties of Anti-Galα1–3Gal Antibodies After Sensitization with Xenogeneic Tissues
33. Modeling And Therapy of Human Liver Diseases Using Induced Pluripotent Stem Cells: How Far Have We Come?
34. Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells
35. Cellular Location of HNF4α is Linked With Terminal Liver Failure in Humans
36. Xenotransplantation and the Liver
37. Contributors
38. Xenotransplantation and liver disease: 403.3
39. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation
40. Cell-Permeable Pentapeptide V5 Inhibits Apoptosis and Enhances Insulin Secretion, Allowing Experimental Single-Donor Islet Transplantation in Mice
41. Prevention of hepatocyte allograft rejection in rats by transferring adenoviral early region 3 genes into donor cells
42. Treatment of the Crigler-Najjar syndrome type 1 with hepatocyte transplantation
43. Preliminary experience with intestinal transplantation in infants and children
44. Hepatocyte transplantation
45. Hepatocyte transplantation
46. Hepatocyte transplantation in liver failure and inherited metabolic disorders
47. Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: reversal of hepatocyte immortalization by site-specific excision of the SV40 T antigen
48. Hepatocyte Transplantation for the Treatment of Human Disease
49. Human Hepatocyte Transplantation: Gene Therapy and More?
50. Brief Report: Treatment of the Crigler-Najjar Syndrome Type I with Hepatocyte Transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.